Dow up 150 points; Mission Produce Shares Slide – ATAI Life…

Dow up 150 points; Mission Produce Shares Slide – ATAI Life…

Facebook
Twitter
LinkedIn

US stocks were mostly higher at the end of trading, with the Dow Jones up around 150 points on Friday.

The Dow rose 0.45% to 33,176.46, while the NASDAQ fell 0.02% to 10,473.83. The S&P 500 was also up 0.42% to 3,838.36.

Look at that: The cheapest stocks in the consumer discretionary sector: Tesla, Ford and more


Leading and lagging sectors


Energy stocks rose 2.8% on Friday. Meanwhile top winner in the sector included GeoPark Ltd GPRKincreased by 10% and Hallador Energy Company HNRGincreased by 12%.


In Friday trading, shares in information technology fell 0.2%.


top heading

Household spending rose 0.1% mom in November, while the consumer spending index rose 5.5% yoy in November. Personal income in the United States rose 0.4% mom in November.

Stock trading UP

  • EXPION360 INC. XPON Shares soared 152% to $2.48 after the company announced it had been selected as the exclusive supplier of high-energy lithium-ion batteries for an Overland trailer built by a leading US sport utility -Vehicle manufacturer to be branded and sold.
  • shares of DBV Technologies SA DBVT got a boost, rising 19% to $1.40 after the company announced that the FDA lifted the partial clinical lockdown of its pivotal Phase 3 VITESSE trial.
  • Immuron Limited IMRN Shares were also higher, gaining 27% to $2.05 after the company received FDA clearance for Travelan’s IND filing.

Stocks are trading down

  • Atai Life Sciences NV ATAI Shares fell 11% to $2.70. The Company announced results from Kures Therapeutics’ Phase 1 study of KUR-10.
  • shares of Mission Produce, Inc. AVO were down 15% to $12.39 after the company reported weaker-than-expected fourth-quarter results on Thursday.
  • Applied Molecular Transport Inc. AMTI declined, falling 58% to $0.43 after the company announced top-line Phase 2 results from the LOMBARD monotherapy study, in which the company observed similar rates of clinical remission in patients who…

[ad_2]

Source story

More to explorer